Takeaway
Four performance measures are evaluated as meaningful indicators of multiple sclerosis (MS)-related disability.
Why this matters?
Existing outcome measures for MS are limited in terms of determining disability and their clinical meaningfulness is difficult to interpret.
A multidimensional outcomes measure of MS-related disability based on clinically meaningful performance tests could be a useful endpoint in future MS studies.